Pedram Hamrah News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pedram hamrah. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pedram Hamrah Today - Breaking & Trending Today

OKYO Pharma shares surge on FDA clearance of Phase 2 neuropathic corneal pain trial

OKYO Pharma shares surge on FDA clearance of Phase 2 neuropathic corneal pain trial
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Garys Jacob , Pedram Hamrah , Tufts Medical Center As Principal Investigator , Okyo Pharma Ltd , Drug Administration , Investigational New Drug , Advisory Board , Tufts Medical Center ,

OKYO Pharma Receives FDA Approval of IND for OK-101 in Neuropathic Corneal Pain

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and for neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA approved . ....

City Of , United Kingdom , Garys Jacob , Pedram Hamrah , Translational Ocular Immunology At Tufts Medical Center , National Organization For Rare Disorders , Drug Administration , Pharma Limited , Company Phase , Tufts Medical Center , Cornea Service , National Organization , Rare Disorders , Investigational New Drug , Vice Chair , Academic Programs , Translational Ocular Immunology , Tufts Medical , Chief Executive ,